BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37205118)

  • 1. The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model.
    Geyer M; Gaul LM; D Agosto SL; Corbo V; Queiroz K
    Front Immunol; 2023; 14():1155085. PubMed ID: 37205118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma.
    Ene-Obong A; Clear AJ; Watt J; Wang J; Fatah R; Riches JC; Marshall JF; Chin-Aleong J; Chelala C; Gribben JG; Ramsay AG; Kocher HM
    Gastroenterology; 2013 Nov; 145(5):1121-32. PubMed ID: 23891972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic Tumor Microenvironment.
    Wang K; He H
    Adv Exp Med Biol; 2020; 1296():243-257. PubMed ID: 34185297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.
    Fu Y; Liu S; Zeng S; Shen H
    Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
    Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
    Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer.
    Ahmad RS; Eubank TD; Lukomski S; Boone BA
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34204306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human pancreatic stellate cells modulate 3D collagen alignment to promote the migration of pancreatic ductal adenocarcinoma cells.
    Drifka CR; Loeffler AG; Esquibel CR; Weber SM; Eliceiri KW; Kao WJ
    Biomed Microdevices; 2016 Dec; 18(6):105. PubMed ID: 27819128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma.
    Tang D; Wang D; Yuan Z; Xue X; Zhang Y; An Y; Chen J; Tu M; Lu Z; Wei J; Jiang K; Miao Y
    Int J Cancer; 2013 Mar; 132(5):993-1003. PubMed ID: 22777597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic Stellate Cells Promote Tumor Progression by Promoting an Immunosuppressive Microenvironment in Murine Models of Pancreatic Cancer.
    Li C; Cui L; Yang L; Wang B; Zhuo Y; Zhang L; Wang X; Zhang Q; Zhang S
    Pancreas; 2020 Jan; 49(1):120-127. PubMed ID: 31856087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nanodrug simultaneously inhibits pancreatic stellate cell activation and regulatory T cell infiltration to promote the immunotherapy of pancreatic cancer.
    Wang R; Hong K; Zhang Q; Cao J; Huang T; Xiao Z; Wang Y; Shuai X
    Acta Biomater; 2023 Oct; 169():451-463. PubMed ID: 37572982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a novel co-culture system using human pancreatic cancer cells and human iPSC-derived stellate cells to mimic the characteristics of pancreatic ductal adenocarcinoma in vitro.
    Kometani T; Kamo K; Kido T; Hiraoka N; Chibazakura T; Unno K; Sekine K
    Biochem Biophys Res Commun; 2023 May; 658():1-9. PubMed ID: 37004297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of an in vitro 3D PDAC stroma rich spheroid model.
    Ware MJ; Keshishian V; Law JJ; Ho JC; Favela CA; Rees P; Smith B; Mohammad S; Hwang RF; Rajapakshe K; Coarfa C; Huang S; Edwards DP; Corr SJ; Godin B; Curley SA
    Biomaterials; 2016 Nov; 108():129-42. PubMed ID: 27627810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomaterial substrate-derived compact cellular spheroids mimicking the behavior of pancreatic cancer and microenvironment.
    Wong CW; Han HW; Tien YW; Hsu SH
    Biomaterials; 2019 Aug; 213():119202. PubMed ID: 31132644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer.
    Li Y; Zhao Z; Lin CY; Liu Y; Staveley-OCarroll KF; Li G; Cheng K
    Theranostics; 2021; 11(5):2182-2200. PubMed ID: 33500719
    [No Abstract]   [Full Text] [Related]  

  • 15. YAP1-mediated pancreatic stellate cell activation inhibits pancreatic cancer cell proliferation.
    Xiao Y; Zhang H; Ma Q; Huang R; Lu J; Liang X; Liu X; Zhang Z; Yu L; Pang J; Zhou L; Liu T; Wu H; Liang Z
    Cancer Lett; 2019 Oct; 462():51-60. PubMed ID: 31352078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
    Zhao W; Ajani JA; Sushovan G; Ochi N; Hwang R; Hafley M; Johnson RL; Bresalier RS; Logsdon CD; Zhang Z; Song S
    Gastroenterology; 2018 Apr; 154(5):1524-1537.e6. PubMed ID: 29274868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming.
    Zhao T; Zhang R; He Q; Zhou H; Song X; Gong T; Zhang Z
    Acta Biomater; 2022 Jun; 145():122-134. PubMed ID: 35381402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma.
    Koikawa K; Ohuchida K; Ando Y; Kibe S; Nakayama H; Takesue S; Endo S; Abe T; Okumura T; Iwamoto C; Moriyama T; Nakata K; Miyasaka Y; Ohtsuka T; Nagai E; Mizumoto K; Hashizume M; Nakamura M
    Cancer Lett; 2018 Jul; 425():65-77. PubMed ID: 29580808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin α11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer.
    Schnittert J; Bansal R; Mardhian DF; van Baarlen J; Östman A; Prakash J
    FASEB J; 2019 May; 33(5):6609-6621. PubMed ID: 30808244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer.
    Liu Y; Li F; Gao F; Xing L; Qin P; Liang X; Zhang J; Qiao X; Lin L; Zhao Q; Du L
    Tumour Biol; 2016 Nov; 37(11):15283-15291. PubMed ID: 27696296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.